Consensus Sotera Health Company

Equities

SHC

US83601L1026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
11.18 ^USD	+0.81%		-0.18%	-33.65%

May. 31	Sotera Health Unit Closes $2.26 Billion of Financing	MT
May. 21	Piper Sandler Initiates Sotera Health at Neutral Rating With $13 Price Target	MT

Evolution of the average Target Price on Sotera Health Company

Price target over the last 5 years

History of analyst recommendation changes

be442673c20da8b9e1edff5a.l_di9VBKloMMg2Q9DTg6QZBokLC-IqRH4UzfDSgIy4E.xMckligyp9FczhZ6Qw1WBfMYvcOKUfAwkSruZUpgoffdqD2tNTjdwjjbAw~aa72f396649d0fd216f02e31b6f1e3e2

Analyst Recommendations on Sotera Health Company

Piper Sandler Initiates Sotera Health at Neutral Rating With $13 Price Target	May. 21	MT
Piper Sandler Starts Sotera Health With Neutral Rating, $13 Price Target	May. 21	MT
Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	Apr. 03	MT
Sotera Health Shares Rise Following Jefferies Upgrade	Mar. 25	MT
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target is $15.50	Mar. 25	MT
Barclays Adjusts Price Target on Sotera Health to $17 From $15, Maintains Overweight Rating	Jan. 25	MT
RBC Cuts Price Target on Sotera Health to $20 From $22, Keeps Outperform Rating	Nov. 02	MT
KeyBanc Adjusts Price Target on Sotera Health to $23 From $24, Maintains Overweight Rating	23-08-04	MT
RBC Raises Price Target on Sotera Health to $22 From $18, Keeps Outperform Rating	23-08-04	MT
Sotera Health Upgraded by KeyBanc to Overweight From Sector Weight Post Settlement of Ethylene Oxide Claims, Price Target Set at $24	23-06-26	MT
Barclays Adjusts Price Target on Sotera Health to $20 From $21, Maintains Overweight Rating	23-05-04	MT
RBC Cuts Price Target on Sotera Health to $18 From $19, Maintains Outperform Rating	23-05-04	MT
Barclays Adjusts Sotera Health Price Target to $21 From $22, Maintains Overweight Rating	23-04-04	MT
RBC Boosts Price Target on Sotera Health to $19 From $8, Maintains Outperform Rating	23-03-01	MT
JPMorgan Upgrades Sotera Health to Neutral From Underweight, Adjusts Price Target to $18 From $6	23-01-23	MT
Barclays Upgrades Sotera Health to Overweight From Underweight, Adjusts Price Target to $22 From $6	23-01-11	MT
Wolfe Research Upgrades Sotera Health to Outperform From Peer Perform, Price Target is $25	23-01-11	MT
Goldman Sachs Adjusts Sotera Health's Price Target to $8 From $9, Keeps Neutral Rating	22-11-23	MT
Barclays Downgrades Sotera Health Company to Underweight From Equalweight, Lowers Price Target to $6 From $7	22-11-15	MT
Barclays Trims Sotera Health Company's Price Target to $7 From $8, Maintains Equalweight Rating	22-11-03	MT
Citigroup Lowers Sotera Health Company's Price Target to $7 From $9, Maintains Neutral Rating	22-11-03	MT
Jefferies Lowers Sotera Health Company's Price Target to $7 From $21, Maintains Hold Rating	22-11-03	MT
JPMorgan Lowers Sotera Health Company's Price Target to $6 From $9, Maintains Underweight Rating	22-11-03	MT
RBC Cuts Price Target on Sotera Health to $8 From $25, Maintains Outperform Rating	22-11-03	MT
Barclays Adjusts Sotera Health's Price Target to $8 From $22, Keeps Equalweight Rating	22-10-06	MT